988 Results

People

  1. Lesokhin
    Lesokhin
  2. Landgren
    Landgren
  3. Hassoun
    Hassoun
  4. Mailankody
    Mailankody
  5. Landau
    Landau
  6. Giralt
    Giralt
  7. Korde
    Korde
  8. Hultcrantz
    Hultcrantz
  9. Chung
    Chung
  10. Shah
    Shah

Groups

  1. Center for Hematologic Malignancies (988)
  2. Department of Medicine (988)
  3. Hematologic Malignancies, Division of (988)
  4. Myeloma (988)
  5. Hematologic Malignancies Research (651)
  6. Survivorship Research (356)
  7. Sloan Kettering Institute Postdocs (292)
  8. Bone Marrow Transplant (289)
  9. Epidemiology and Biostatistics (209)
  10. Biostatistics Service (175)
  1. "Myeloma"
Formats
  1. Meeting Abstract (543)
  2. Journal Article (358)
  3. Review (36)
  4. Research Letter (19)
  5. Book Section (10)
  6. Guidelines (10)
  7. Correspondence (6)
  8. Editorial (5)
  9. Conference Paper (1)
Groups
  1. Center for Hematologic Malignancies (988)
  2. Department of Medicine (988)
  3. Hematologic Malignancies, Division of (988)
  4. Myeloma (988)
  5. Hematologic Malignancies Research (651)
  6. Survivorship Research (356)

More Groups

People
  1. Alexander Lesokhin (363)
  2. Carl Landgren (336)
  3. Hani Hassoun (329)
  4. Sham Mailankody (282)
  5. Malin Hultcrantz (260)
  6. Heather Landau (239)

More People

Years
  1. 2025 (13)
  2. 2024 (69)
  3. 2023 (115)
  4. 2022 (96)
  5. 2021 (76)
  6. 2020 (95)

More Years

Publications
  1. Blood (303)
  2. Clinical Lymphoma, Myeloma and Leukemia (96)
  3. Journal of Clinical Oncology (85)
  4. Haematologica (41)
  5. Biology of Blood and Marrow Transplantation (29)
  6. Blood Cancer Journal (22)

More Publications

Publishers
  1. American Society of Hematology (324)
  2. Elsevier Inc. (159)
  3. American Society of Clinical Oncology (87)
  4. Nature Publishing Group (83)
  5. Ferrata Storti Foundation (41)
  6. American Association for Cancer Research (34)

More Publishers

Results (988)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting B-cell maturation antigen (BCMA) with GSK2857916 antibody-drug conjugate provides durable responses in patients (Pts) with heavily-pretreated relapsed/refractory multiple myeloma (RRMM): Preliminary results from study BMA117159
    Meeting Abstract

    Popat, R.; Trudel, S.; Lendvai, N.; Voorhees, P.; Reeves, B.; Libby, E.; Richardson, P.; Anderson, L. Jr; Sutherland, H.; Yong, K.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • Melflufen therapy for heavily pretreated relapsed refractory multiple myeloma (RRMM) patients refractory to daratumumab and/or pomalidomide: Early efficacy data (Horizon)
    Meeting Abstract

    Mateos, M. V.; Oriol Rocafiguera, A.; Rodríguez-Otero, P.; Bladé, J.; Larocca, A.; Moreb, S. J.; Cavo, M.; Mazumder, A.; Alegre, A.; Hassoun, H.; more...
    Haematologica (2018)

    Fulltext@MSK | Save
  • MRD testing in multiple myeloma: From a surrogate marker of clinical outcomes to an every-day clinical tool
    Journal Article

    Landgren, O.
    Seminars in Hematology (2018)

    Fulltext@MSK | Save
  • MRD testing in multiple myeloma: The main future driver for modern tailored treatment
    Journal Article

    Landgren, O.; Lu, S. X.; Hultcrantz, M.
    Seminars in Hematology (2018)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance
    Book Section

    Hultcrantz, M.; Landgren, O.
    In Wiernik, P. H.; Dutcher, J. P.; Gertz, M. A. (Eds.) Neoplastic Diseases of the Blood. 6th ed (2018)

    Fulltext@MSK | Save
  • In-situ protein expression analysis of B-cell maturation antigen (BCMA)
    Meeting Abstract

    Jungbluth, A.; Dogan, A.; Frosina, D.; Fayad, M.; Smith, E.
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Revaccination after autologous hematopoietic stem cell transplantation is safe and effective in patients with multiple myeloma receiving lenalidomide maintenance
    Journal Article

    Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Maloy, M.; Kenny, S.; Hassoun, H.; Korde, N. S.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • In reply
    Journal Article

    Prasad, V.; Mailankody, S.
    JAMA Internal Medicine (2018)

    Fulltext@MSK | Save
  • Host-related immunodeficiency in the development of multiple myeloma
    Journal Article

    Dosani, T.; Mailankody, S.; Korde, N.; Manasanch, E.; Bhutani, M.; Tageja, N.; Roschewski, M.; Kwok, M.; Kazandjian, D.; Costello, R.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save
  • Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: Phase 2 trial results
    Journal Article

    Richardson, P. G.; Bensinger, W. I.; Huff, C. A.; Costello, C. L.; Lendvai, N.; Berdeja, J. G.; Anderson, L. D. Jr; Siegel, D. S.; Lebovic, D.; Jagannath, S.; more...
    British Journal of Haematology (2018)

    Fulltext@MSK | Save